Kalamazoo-based medical device company C2Dx recently announced expansion of the company through its acquisition of Hemostatix, a thermal scalpel blade that seals blood vessels as they are incised. Formerly known as the Shaw Scalpel, the thermal scalpel features a five-layer laminate composition of copper and stainless steel.
Varnum represented C2Dx in all aspects of the transaction, including negotiating the asset purchase agreement and all other legal documents. Pete Roth and Chris George led the M&A team which included John Sturgis (real estate), Staci DeRegnaucourt (intellectual property) and Shawn Strand (tax).
Founded in early 2019 by industry experts, C2Dx invests in and refines the delivery of valuable, niche products to propel their growth and accessibility worldwide. Varnum previously worked with the company in its acquisition of the TPump product line from Stryker Corporation.